1. A total of 4,811 differentially expressed genes were identified, among which PDHA1 and CDKN2A were significantly differentially expressed between osteosarcoma and controls2. PDHA1 and CDKN2A were identified as specific cuproptosis-related biomarkers for osteosarcoma. This evidence concerns the gene CDKN2A and osteosarcoma.